China Shineway Pharmaceutical Group Limited (HKG:2877)
Hong Kong · Delayed Price · Currency is HKD 9.20
+0.56 (6.48%)
At close: Mar 27, 2026
HKG:2877 Revenue
In the year 2025, China Shineway Pharmaceutical Group had annual revenue of 3.14B CNY, down -17.01%. China Shineway Pharmaceutical Group had revenue of 1.65B in the half year ending June 30, 2025, a decrease of -31.10%.
Revenue
3.14B CNY
Revenue Growth
-17.01%
P/S Ratio
1.99
Revenue / Employee
1.09M CNY
Employees
2,867
Market Cap
6.95B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.14B | -642.62M | -17.01% |
| Dec 31, 2024 | 3.78B | -738.50M | -16.35% |
| Dec 31, 2023 | 4.52B | 565.90M | 14.32% |
| Dec 31, 2022 | 3.95B | 727.09M | 22.56% |
| Dec 31, 2021 | 3.22B | 567.85M | 21.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition